Skip to content

Measuring Quality of Decisions About Treatment of Menopausal Symptoms

Measuring Quality of Decisions About Treatment of Menopausal Symptoms

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01152294
Enrollment
401
Registered
2010-06-29
Start date
2010-06-30
Completion date
2010-11-30
Last updated
2012-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause

Keywords

Menopause, Decision making, Decision aids, Decision quality instrument

Brief summary

The purpose of this randomized controlled trial is to examine the impact of a patient decision aid on the quality of decisions about managing symptoms of menopause. In particular, we will examine whether the decision aid increases knowledge about menopause/managing menopause symptoms and concordance between goals and treatment choices.

Interventions

BEHAVIORALDVD & Booklet called: Managing Menopause

DVD and booklet that provides information about treatment choices for menopause symptoms. Complete title: Managing Menopause: Choosing treatments for menopause symptoms

Sponsors

Foundation for Informed Medical Decision Making
CollaboratorOTHER
Massachusetts General Hospital
CollaboratorOTHER
University of Massachusetts, Boston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Female, aged 40-60 * Talked with health care provider about ways to manage menopause within last year OR seriously considered taking medicine or supplement to manage menopause within the last year

Exclusion criteria

* Prior diagnosis of breast cancer * Surgical or medically induced menopause (ovaries removed)

Design outcomes

Primary

MeasureTime frameDescription
Menopause Knowledge2 weeks, on averageTotal knowledge score from factual questions about menopause and methods for managing menopause symptoms. Score is the percent of knowledge questions answered correctly (0 - 100%)

Secondary

MeasureTime frameDescription
Value Concordance2 weeks, on averageMeasure of how concordant respondents' actual decisions about treatment for their menopause symptoms are with their stated beliefs

Countries

United States

Participant flow

Recruitment details

Participants were recruited through online and newspaper ads by the Center for Survey Research in 17 cities: Atlanta, Baltimore, Boston, Chicago, Dallas-Ft. Worth, Denver, Detroit, Ft. Myers, Houston, Los Angeles, Minneapolis, New York, Phoenix, Portland, Raleigh-Durham, San Francisco, Washington, D.C.

Pre-assignment details

Participants were randomized to receive a DVD and booklet or no DVD and to participate by phone or IVR (automated telephone survey system).

Participants by arm

ArmCount
Control
Group not receiving the decision aid (DVD and booklet)
213
Decision Aid
Group receiving the decision aid (DVD/booklet)
188
Total401

Baseline characteristics

CharacteristicDecision AidControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
2 Participants1 Participants3 Participants
Age, Categorical
Between 18 and 65 years
186 Participants212 Participants398 Participants
Age Continuous51 years
STANDARD_DEVIATION 5.5
51 years
STANDARD_DEVIATION 5.1
51 years
STANDARD_DEVIATION 5.3
Region of Enrollment
United States
188 participants213 participants401 participants
Sex: Female, Male
Female
188 Participants213 Participants401 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 2130 / 188
serious
Total, serious adverse events
0 / 2130 / 188

Outcome results

Primary

Menopause Knowledge

Total knowledge score from factual questions about menopause and methods for managing menopause symptoms. Score is the percent of knowledge questions answered correctly (0 - 100%)

Time frame: 2 weeks, on average

Population: Participants were randomized to not receive the decision aid (DVD and booklet)or to receive the decision aid and booklet.

ArmMeasureValue (MEAN)Dispersion
ControlMenopause Knowledge51.3 Percentage (0-100%)Standard Deviation 16
Decision AidMenopause Knowledge55.8 Percentage (0-100%)Standard Deviation 18.4
Comparison: We tested for a difference in the mean total knowledge score between the decision aid and control groups using independent t-test (2 sided). With 100 patients in each arm, the study had more than 90% power to detect a 10% difference in knowledge assuming a common standard deviation of 18%.p-value: 0.0195% CI: [1.02, 7.96]t-test, 2 sided
Secondary

Value Concordance

Measure of how concordant respondents' actual decisions about treatment for their menopause symptoms are with their stated beliefs

Time frame: 2 weeks, on average

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026